PATRICIA CORBO: Open Payments
NPI 1689048936 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 46 payments from 14 companies in 2025. Trend: 2023 $665 · 2024 $1,387 · 2025 $917
Food & beverage: $899Education: $17
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $182 |
| AstraZeneca Pharmaceuticals LP | 3 | $136 |
| GlaxoSmithKline, LLC. | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| GENZYME CORPORATION | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Grifols USA, LLC | 2 | $55 |
| Viatris Specialty LLC | 3 | $49 |
| Baxter Healthcare | 2 | $47 |
| Verona Pharma, Inc. | 2 | $43 |
Products named: GLASSIA, DUPIXENT, BREZTRI, TRELEGY ELLIPTA, OFEV, Prolastin-C Liquid, YUPELRI, Hillrom - Vest System Model 105 Home Care.
Industry payments across FL — which companies pay providers there.
